Hostname: page-component-669899f699-b58lm Total loading time: 0 Render date: 2025-05-04T09:08:28.380Z Has data issue: false hasContentIssue false

Can Medical Licensing Boards Swing the Pendulum Towards Judicious Opioid Prescribing Practices?

Published online by Cambridge University Press:  16 December 2024

Lewis S. Nelson
Affiliation:
RUTGERS NEW JERSEY MEDICAL SCHOOL, NEWARK, NEW JERSEY, USA
Jeanmarie Perrone
Affiliation:
UNIVERSITY OF PENNSYLVANIA, PHILADELPHIA, PENNSYLVANIA, USA

Extract

In the initial wave of the opioid crisis, uninformed prescribing practices and lax oversight were the drivers of opioid addiction and death. Although opioid prescriptions have decreased by 44.4 percent between 2011-2020,1 the number of deaths linked to prescription opioids has decreased only marginally.2 The marked fall in opioid prescribing without a concomitant reduction in opioid-related deaths suggests that an at-risk population continued to receive prescription opioids, whether directly or indirectly, from a medical professional. Currently, illicitly manufactured fentanyl (IMF) is the culprit for the majority of the approximately 81,000 annual opioid-related deaths.3 This finding has been misleadingly used to suggest that prescription opioids for chronic pain are no longer (and never were) a relevant concern,4 while the reality is that their lethal consequences are simply dwarfed by the marked rise in IMF deaths.5

Type
Commentary
Copyright
© The Author(s), 2024. Published by Cambridge University Press on behalf of American Society of Law, Medicine & Ethics

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

American Medical Association, Press Release, Report Shows Decreases in Opioid Prescribing, Increase in Overdoses (September 21, 2021), available at <https://www.ama-assn.org/press-center/press-releases/report-shows-decreases-opioid-prescribing-increase-overdoses> (last visited September 10, 2024).+(last+visited+September+10,+2024).>Google Scholar
National Center for Health Statistics, Centers for Disease Control and Prevention, Drug Overdose Death Rates, National Institute on Drug Abuse, available at < https://nida.nih.gov/research-topics/trends-statistics/overdose-death-rates> (last visited September 10, 2024).+(last+visited+September+10,+2024).>Google Scholar
Nadeau, S.E. and Lawhern, R.A., “Origins of Opioid Crisis More Complex Than Stated,” Pain Medicine News, July 13, 2022, available at <https://www.painmedicinenews.com/Commentary/Article/07-22/Origins-of-Opioid-Crisis-More-Complex-Than-Stated/67397> (last visited September 10, 2024).+(last+visited+September+10,+2024).>Google Scholar
5. See supra note 2.Google Scholar
Dowell, D., Haegerich, T.M, and Chou, R., “CDC Guideline for Prescribing Opioids for Chronic Pain — United States, 2016,” MMWR Recommendations and Reports 65, no. 1 (2016): 149, doi: https://doi.org/10.15585/mmwr.rr6501e1.CrossRefGoogle Scholar
7. Liao, J.M. et al., “How Physician Self-Perceptions Affect the Impact of Peer Comparison Feedback on Opioid Prescribing,” American Journal of Medical Quality 38, no. 3 (2023): 129–36, doi: https://doi.org/10.1097/jmq.0000000000000117.CrossRefGoogle ScholarPubMed
Galletly, C.L. et al., “Out of Bounds: Physician Licensing Board Disciplinary Cases Related to Opioid Prescribing,” Journal of Law, Medicine & Ethics 53, no. 2 (2024): 677687.Google Scholar
Lozada, M.J. et al., “Opioid Prescribing by Primary Care Providers: A Cross-Sectional Analysis of Nurse Practitioner, Physician Assistant, and Physician Prescribing Patterns,” Journal of General Internal Medicine 35, no. 9 (2020): 2584–92, doi: https://doi.org/10.1007/s11606-020-05823-0.CrossRefGoogle ScholarPubMed
Van Zee, A., “The Promotion and Marketing of Oxycontin: Commercial Triumph, Public Health Tragedy,” American Journal of Public Health 99, no. 2 (2009): 221–27, doi: https://doi.org/10.2105/ajph.2007.131714.CrossRefGoogle ScholarPubMed
Guy, G.P. and Zhang, K., “Opioid Prescribing by Specialty and Volume in the U.S.,” American Journal of Preventive Medicine 55, no. 5 (2018): e15355, doi: https://doi.org/10.1016/j.amepre.2018.06.008.CrossRefGoogle ScholarPubMed
Gray, B. M. et al., “Clinical Knowledge and Trends in Physicians’ Prescribing of Opioids for New Onset Back Pain, 2009-2017,” JAMA Network Open 4, no. 7 (2021): e2115328, doi: https://doi.org/10.1001/jamanetworkopen.2021.15328.CrossRefGoogle ScholarPubMed
REMS Program Committee, Opioid Analgesic REMS for Accredited Continuing Education Providers, OpiodAnalgesicREMS.com, available at <https://www.opioidanalgesicrems.com/CEProviders.html> (last visited September 10, 2024).+(last+visited+September+10,+2024).>Google Scholar
Xiulu Ruan v. United States, 597 U.S. 450 (2022), available at <https://www.supremecourt.gov/opinions/21pdf/20-1410_1an2.pdf> (last visited September 10, 2024).+(last+visited+September+10,+2024).>Google Scholar
Gershowitz, A., “The Opioid Doctors: Is Losing Your License a Sufficient Penalty for Dealing Drugs?,” Hastings Law Journal 72 no. 3 (2021), available at <https://repository.uchastings.edu/hastings_law_journal/vol72/iss3/4> (last visited September 10, 2024).Google Scholar
Lozada, supra note 9.Google Scholar
Light, A. E. et al., “Relationships Between Stigma, Risk Tolerance, and Buprenorphine Dispensing Intentions Among Community-Based Pharmacists: Results From a National Sample,” Substance Use & Addiction Journal 45, no. 2 (2024): 211–21, doi: https://doi.org/10.1177/29767342231215178.CrossRefGoogle ScholarPubMed